Press release content from PR Newswire. The AP news staff was not involved in its creation.
Everlywell Signs Agreement to Distribute FDA-Authorized Rapid Antigen Testing for Organizations and Public Health Agencies
January 8, 2021 GMT
Founded in 2015, Everlywell was created to modernize the lab testing experience. Today the company offers a suite of validated lab tests that anyone can take at home. www.everlywell.com (PRNewsfoto/EverlyWell)
Founded in 2015, Everlywell was created to modernize the lab testing experience. Today the company offers a suite of validated lab tests that anyone can take at home. www.everlywell.com (PRNewsfoto/EverlyWell)
AUSTIN, Texas, Jan. 8, 2021 /PRNewswire/ Everlywell, a leading digital health company and provider of one of the only FDA-authorized at-home sample collection kits for COVID-19, today announced it has signed an agreement with leading life sciences company Ginkgo Bioworks to distribute Access Bio’s FDA-authorized CareStart™ COVID-1